Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04537208
Recruitment Status : Active, not recruiting
First Posted : September 3, 2020
Last Update Posted : January 27, 2021
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Sanofi ( Sanofi Pasteur, a Sanofi Company )